News from Abchurch

Healthy demand for Abchurch’s MBO and de-listing experience

05 February 2009

Abchurch’s long-term relationship with leading healthcare IT provider, Ascribe, has stepped up a gear as the Company undergoes a management buy-out and AIM delisting.

Abchurch supported Ascribe’s £5m AIM listing in December 2004 and has effectively grown the Company’s media and analyst following on the back of its meteoric expansion in the UK, Australia, New Zealand, Malaysia and Hong Kong – including eight acquisitions in three years.

The Ascribe Board recommended an MBO offer price of 28p per share on 17th December 2008 representing a premium of 55.6 per cent to the flotation price.

MBO coverage to date for Bolton-based Ascribe has included The Financial Times, The Independent, City AM, The Manchester Evening News and The Bolton News as well as a number of trade publications such as e-Health Insider, Health Equipment & Supplies and Hospital IT Europe – leveraging Abchurch’s strong media links out of its London and Northern region offices.

Media enquiries:
Justin Heath
justin.heath@abchurch-group.com
Tel: +44 (0)20 7398 7781